Advertisement

Miscellaneous

  • Venerino Poletti
  • Antonella Arcadu
  • Christian Gurioli
  • Fabio Sultani
  • Linda Tagliaboschi
  • Carlo Gurioli
  • Giovanni Poletti
Chapter

Abstract

In this chapter examples of rare entities or of rare pulmonary manifestations of systemic disorders, rarely documented by biopsy, are described.

Keywords

Pulmonary alveolar proteinosis Drug-induced lung disorders Granulomatous-lymphocytic interstitial lung disease 

References

  1. 1.
    Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med. 1958;258:1123–42.CrossRefGoogle Scholar
  2. 2.
    Kumar A, Abdelmalak B, Inoue Y, Culver DA. Pulmonary alveolar proteinosis: pathophysiology and clinical approach. Lancet Respir Med. 2018;6:554–65.CrossRefGoogle Scholar
  3. 3.
    McReynolds LJ, Calvo KR, Holland SM. Germline GATA2 mutation and bone marrow failure. Hematol Oncol Clin North Am. 2018;32:713–28.CrossRefGoogle Scholar
  4. 4.
    Marchand-Adam S, Diot B, Magro P, et al. Pulmonary alveolar proteinosis revealing a telomerase disease. Am J Respir Crit Care Med. 2013;188:402–4.CrossRefGoogle Scholar
  5. 5.
    Akira M, Inoue Y, Arai T, et al. Pulmonary fibrosis on high-resolution CT of patients with pulmonary alveolar proteinosis. AJR. 2016;207:544–51.CrossRefGoogle Scholar
  6. 6.
    Colby TV, Carrington CB. Interstitial lung disease. In: Thurlbeck WM, Churg AM, editors. Pathology of the lung. Stuttgart: Thieme Medical Publishers; 1995. p. 589–737.Google Scholar
  7. 7.
  8. 8.
    Dulohery MM, Maldonado F, Limper AH. Drug induced pulmonary disease. In: Broaddus VC, Mason RJ, Ernst JD, King TE, Lazarus SC, Murray JF, Nadel JA, Slutsky AS, Gotway MB, editors. Murray & Nadel’s textbook of respiratory medicine. Philadelphia: Saunders; 2016. p. 1275–94.CrossRefGoogle Scholar
  9. 9.
    Romagnoli M, Bigliazzi C, Casoni G, et al. The role of transbronchial lung biopsy for the diagnosis of diffuse drug-induced lung disease: a case series of 44 patients. Sarcoidosis Vasc Diffuse Lung Dis. 2008;25:36–45.PubMedGoogle Scholar
  10. 10.
    Cinetto F, Scarpa R, Rattazzi M, Agostini C. The broad spectrum of lung diseases in primary antibody deficiency. Eur Respir Rev. 2018;27:180019.CrossRefGoogle Scholar
  11. 11.
    Sood AK, Funkhouser W, Handly B, Weston B, Wu EY. Granulomatous-lymphocytic interstitial lung disease in 22q11.2 deletion syndrome: a case report and literature review. Curr Allergy Asthma Rep. 2018;18:14.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Venerino Poletti
    • 1
    • 2
  • Antonella Arcadu
    • 1
  • Christian Gurioli
    • 1
  • Fabio Sultani
    • 1
  • Linda Tagliaboschi
    • 1
  • Carlo Gurioli
    • 1
  • Giovanni Poletti
    • 3
  1. 1.Department of Diseases of the ThoraxOspedale Morgagni-PierantoniForlìItaly
  2. 2.Department of Respiratory Diseases and AllergyAarhus University HospitalAarhusDenmark
  3. 3.Hematologic Section, CorelabAzienda USL Romagna, PievesestinaCesenaItaly

Personalised recommendations